You have 9 free searches left this month | for more free features.

Antibodies, Monoclonal

Showing 7276 - 7300 of 7,894

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer Trial in United Kingdom, United States (Volociximab, Gemcitabine)

Completed
  • Pancreatic Cancer
  • Pittsburgh, Pennsylvania
  • +5 more
Jan 28, 2013

Osteoarthritis, Pain Trial in London Bridge (MEDI-578, Placebo for MEDI-578)

Terminated
  • Osteoarthritis
  • Pain
  • London Bridge, Greater London, United Kingdom
    Research Site
Jan 28, 2013

Interstitial Lung Disease Trial in Barcelona (Biopsy by cryoprobes, Biopsy with conventional forceps)

Completed
  • Interstitial Lung Disease
  • Biopsy by cryoprobes
  • Biopsy with conventional forceps
  • Barcelona, Spain
    Hospital de la Sanrta Creu i Sant Pau
Jan 21, 2013

Esophageal Cancer Trial in United Kingdom (biological, drug, radiation)

Unknown status
  • Esophageal Cancer
  • cetuximab
  • +3 more
  • Birmingham, England, United Kingdom
  • +54 more
Dec 17, 2012

Arthritis, Rheumatoid Trial (Part A, Part B)

Completed
  • Arthritis, Rheumatoid
  • Part A
  • Part B
  • (no location specified)
Nov 8, 2012

Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery

Completed
  • Thrombosis
  • Rochester, Minnesota
  • +3 more
Feb 22, 2013

Elitek (Rasburicase) Immuno-Monitoring Study

Terminated
  • Tumor Lysis Syndrome
    • Valhalla, New York
    • +3 more
    Jan 30, 2013

    Epidermal Growth Factor Receptor Inhibitor Therapy in Skin of

    Completed
    • Solid Tumor
    • enzyme inhibitor therapy
    • +4 more
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Aug 31, 2012

    Renal Cell Cancer Trial in Houston (Fludarabine, Melphalan, Cyclophosphamide)

    Terminated
    • Renal Cell Cancer
    • Houston, Texas
      U.T. M.D. Anderson Cancer Center
    Feb 26, 2013

    Healthy Trial in Tacoma (PF-05230905)

    Completed
    • Healthy
    • Tacoma, Washington
      Investigational Site
    Jan 30, 2013

    HTLV-I Infection, T Cell Leukemia Trial run by the NCI (daclizumab)

    Completed
    • HTLV-I Infection
    • T Cell Leukemia
    • daclizumab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 13, 2012

    Lymphoma Trial in Canada (rituximab, bortezomib, cyclophosphamide)

    Completed
    • Lymphoma
    • rituximab
    • +4 more
    • Edmonton, Alberta, Canada
    • +18 more
    Nov 26, 2012

    Plasmodium Falciparum Malaria Trial in Houston (Aluminum Phosphate, Placebo, EBA-175 RII-NG Malaria Vaccine)

    Completed
    • Plasmodium Falciparum Malaria
    • Aluminum Phosphate
    • +2 more
    • Houston, Texas
      Baylor College of Medicine - Molecular Virology and Microbiology
    Apr 11, 2013

    Multiple Myeloma Trial in United States (Elotuzumab (HuLuc63))

    Terminated
    • Multiple Myeloma
    • Elotuzumab (HuLuc63)
    • Los Angeles, California
    • +7 more
    Aug 22, 2012

    Bone Mineralization Defect Trial in Loma Linda, Los Angeles (Vitamin D2)

    Unknown status
    • Bone Mineralization Defect
    • Vitamin D2
    • Loma Linda, California
    • +1 more
    Feb 22, 2013

    Prophylaxis of Venous Thromboembolic Events Trial in Worldwide (TB-402, Rivaroxaban)

    Completed
    • Prophylaxis of Venous Thromboembolic Events
    • Linz, Austria
    • +35 more
    Aug 22, 2012

    Respiratory Syncytial Virus Infections, Chronic Lung Disease and <= 24 Months of Age or, Premature With Gestational Age <=35

    Completed
    • Respiratory Syncytial Virus Infections
    • +2 more
    • Motavizumab, palivizumab
    • +2 more
    • Garran, Australian Capital Territory, Australia
    • +18 more
    Nov 13, 2012

    Metastatic Cancer, Prostate Cancer Trial in Worldwide (strontium chloride Sr 89)

    Completed
    • Metastatic Cancer
    • Prostate Cancer
    • strontium chloride Sr 89
    • Brussels, Belgium
    • +20 more
    Sep 20, 2012

    Crohn's Disease, Colitis, Intestinal Disease Trial in Canada, United States (anti-Interferon-gamma mAb)

    Completed
    • Crohn's Disease
    • +4 more
    • anti-Interferon-gamma monoclonal antibody
    • Anaheim, California
    • +18 more
    Mar 9, 2012

    Follicular Lymphoma Trial in Pavia (Immunochemo, in vivo purging and autrotransplant)

    Completed
    • Follicular Lymphoma
    • Immunochemotherapy, in vivo purging and autrotransplant
    • Pavia, Italy
      Division of Hematology, IRCCS Policlinico S. Matteo, University
    Oct 26, 2012

    Lymphoma Trial in Los Angeles (bortezomib + rituximab)

    Completed
    • Lymphoma
    • bortezomib + rituximab
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center at UCLA
    Oct 3, 2012

    Respiratory Virus Infections In Children Undergoing

    Completed
    • Respiratory Virus Infections
    • Nasopharyngeal Washes
    • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Sep 6, 2012

    Glomerulonephritis, Membranoproliferative Trial in Rochester (Rituximab)

    Completed
    • Glomerulonephritis, Membranoproliferative
    • Rochester, Minnesota
      Mayo Clinic
    Jan 15, 2013

    Lymphoma, Mantle-Cell Trial in Vicenza (Rituximab, Bendamustine, Cytarabine)

    Completed
    • Lymphoma, Mantle-Cell
    • Rituximab, Bendamustine, Cytarabine
    • Vicenza, VI, Italy
      Department of Hematology, Ospedale San Bortolo
    Sep 25, 2012

    Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic Trial (1 mg/kg CNTO 136, 4 mg/kg CNTO 136, 10 mg/kg CNTO 136)

    Completed
    • Lupus Erythematosus, Cutaneous
    • Lupus Erythematosus, Systemic
    • 1 mg/kg CNTO 136
    • +3 more
    • (no location specified)
    Oct 5, 2012